Skip to main content
Log in

Psychiatric comorbidities increase costs in patients with MDD

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2018 euros

Reference

  • Kan K, et al. Real-World Treatment Costs and Care Utilization in Patients with Major Depressive Disorder With and Without Psychiatric Comorbidities in Specialist Mental Healthcare. PharmacoEconomics : 16 Mar 2021. Available from: URL: http://doi.org/10.1007/s40273-021-01012-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Psychiatric comorbidities increase costs in patients with MDD. PharmacoEcon Outcomes News 875, 27 (2021). https://doi.org/10.1007/s40274-021-7606-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7606-2

Navigation